Moderate Hypofractionated Helical Tomotherapy for Older Patients with Localized Prostate Cancer: Long-term Outcomes of a Phase I–II Trial

BACKGROUND: Our previous study showed that two different regimens of moderate hypofractionated radiotherapy (HFRT) delivered with helical tomotherapy (HT) are well tolerated in older prostate cancer patients. We provide a longterm efficacy and toxicity after > 7 years of follow-up. PATIENTS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Di, Du, Lei, Yu, Wei, Cai, Boning, Meng, Lingling, Yang, Jun, Luo, Yanrong, Chen, Jing, Ma, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122298/
https://www.ncbi.nlm.nih.gov/pubmed/35344645
http://dx.doi.org/10.2478/raon-2022-0011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122298/
https://www.ncbi.nlm.nih.gov/pubmed/35344645
http://dx.doi.org/10.2478/raon-2022-0011

Ejemplares similares